30th Napa Pain Conference

Learning Objectives

As a result of participating in this activity, learners will be able/better able to:

• Set expectations for patents as to the duration and degree of relief that Radiofrequency Ablation procedures may provide
• Improve the safety of target-selection for Radiofrequency Ablation

Desirable Physician Attributes

• Patient Care [ACGME/ABMS] Provide care that is compassionate, appropriate and effective for the treatment of health problems and the promotion of health
• Medical Knowledge [ACGME/ABMS] about established and evolving biomedical, clinical, and cognate (e.g. epidemiological and social-behavioral) sciences and the application of this knowledge to patient care
• Employ Evidenced-based Practice [IOM] Integrate best research with clinical expertise and patient values for optimum care, and participate in learning and research activities to the extent feasible

Pain management domains and core competencies

• 1. Multidimensional nature of pain: What is pain?
  • Describes the complex, multidimensional, and individual-specific nature of pain
  • Demonstrates knowledge of the theories and science for understanding the physiology of pain and
    pain transmission
  • Demonstrates knowledge of the terminology for describing pain, including acute pain, chronic pain,
    and pain at the end of life

• 2. Pain assessment and measurement: How is pain assessed and measured?
  • Uses and models language that destigmatizes pain, reflects a whole-person perspective, builds a therapeutic alliance, and promotes behavior change
  • Demonstrates empathic, compassionate, and professional communication during pain assessment

• 3. Treatment: How is pain safely and effectively treated?
  • Identifies and describes potential pharmacological and nonpharmacological treatment options
  • Develops a pain treatment plan based on benefits and risks of available treatments

Accreditation & Designation

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Financial Relationships & Measures to Resolve of Conflicts of Interest

[Presenter] Hemant Kalia discloses the following financial relationships within the past 24 months: Speaking: Averitas; Consulting: Abbott, Averitas

No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).

Learning Objectives

As a result of participating in this activity, learners will be better able/better-able to:

• identify patients & conditions associated with nociplastic pain
• improve decision-making when faced with individuals with nociplastic pain or suspected central sensitization

Accreditation & Designation

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes discussions and explorations of new and evolving topics. Such inclusion includes adequate justifications of statements based upon current science, evidence and clinical reasoning.

Disclosure of Financial Relationships & Measures to Resolve of Conflicts of Interest

Presenter: Steven Cohen discloses the following financial relationships within the past 24 months: Consulting: Avanos, SPR Therapetucs, Persica, SWORD, Scilex Research: Avanos, SPR Therapetucs, SWORD, Scilex

No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).

Learning Objectives

As a result of participating in this activity, learners will be better able/better-able to:

• mitigate common challenges in managing nociplastic pain faced by both patients and providers
• employ strategies to enhance pain care for patients with nociplastic pain

Accreditation & Designation

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes discussions and explorations of new and evolving topics. Such inclusion includes adequate justifications of statements based upon current science, evidence and clinical reasoning.

Disclosure of Financial Relationships & Measures to Resolve of Conflicts of Interest

Presenter: Roger Fillingim discloses the following financial relationships within the past 24 months: Consulting: UCB

No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).

Learning Objectives

As a result of participating in this activity, learners will be better able/better-able to:

• differentiate between nociceptive pain, neuropathic pain, and nociplastic pain
• identify subdivisions of nociplastic pain development 
• utilized an improved understanding of the pathophysiology of nociplastic pain to personalize patient care

Accreditation & Designation

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes discussions and explorations of new and evolving topics. Such inclusion includes adequate justifications of statements based upon current science, evidence and clinical reasoning.

Disclosure of Financial Relationships & Measures to Resolve of Conflicts of Interest

Presenter: Eric Grigsby discloses the following financial relationships within the past 24 months: Research: Seikagaku Corporation, Eli Lilly, Xalud, Medtronic, Neuronetics, NatureCell

No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).

Learning Objectives

As a result of participating in this activity, learners will be better able/better-able to:

• address systems barriers in order to improve safe opioid prescribing at an institutional level

Accreditation & Designation

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Financial Relationships & Measures to Resolve of Conflicts of Interest

Presenter: Shalini Shah discloses the following financial relationships within the past 24 months: Consulting: SPR Therapeutics, Masimo Corporation, Allergan

No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).